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Alpha-hemolysin (HlyA) is a Repeat-in-ToXin (RTX) protein exotoxin produced 
by uropathogenic strains of Escherichia coli. The RTX family of bacterial exotoxins 
constitute a group of related cytolytic proteins that are produced by a wide variety of 
gram-negative human and animal pathogens. While diverse in their associated diseases 
and in their target cell specificities, they share common structural and functional features, 
genetic organization, and many cellular effects. Two distinct groups ofRTX toxins have 
been identified, based on their target cell specificity: leukotoxins and hemolysins. 
Leukotoxins display the highest target cell specificity, affecting only ruminant leukocytes 
and platelets, whereas hemolysins attack a wide variety of animal species and cell types. 
Hly A affects a variety of target cells, ranging from ruminant erythrocytes (RBCs) to 
human leukocytes, which constitute the first line of defense against bacterial infection. 
Irrespective of their target cell specificity, RTX toxins injure target cells by interacting 
with plasma membranes, causing flux of ions and solutes across phospholipid bilayers 
(Welch et al, 1981). Studies conducted by Czuprynski, et al (1991), Ortiz-Carranza & 
Czuprynski (1992), and Cudd et al (1999) indicated that exposure of neutrophils to the 
RTX toxin, Mannheimia haemolytica leukotoxin (LktA), resulted in increased 
intracellular Ca2+ concentration ([Ca2+]i) as well as Ca2+-dependent stimulation of 
oxidative activity. Increased [Ca2+]i also stimulates synthesis and release of 
inflammatory eicosanoids, such as L TB4, which is a potent chemotactic agent for bovine 
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neutrophils. Stimulation of L TB4 release follows Ca2+ -dependent activation of 
phospholipase A2 and phospholipase D, which provide the arachidonic acid substrate 
used in the production of eicosanoids (Wang et al, 1998; Wang et al, 1999). Calcium-
dependent release of inflammatory mediators from human leukocytes and platelets 
exposed to illy A has also been observed (Konig et al, 1994), thus demonstrating that 
many of the effects of RTX toxins on target cells, particularly at sublytic concentrations, 
appear to be mediated by increase in [Ca2+]i. Therefore, the mechanisms involved in 
IDyA-induced increase in [Ca2+]i must be clearly understood before rational strategies to 
combat the effects of this important virulence factor can be developed. 
Increase in [Ca2+]i of illy A-exposed leukocytes could be caused by influx of Ca2+ 
across the plasma membrane (down a concentration gradient from 1.0 - 1.5 mM to 0.1 
µM in the cytosol) and/or by release of Ca2+ from intracellular stores. The former 
mechanism has been the subject of several investigations that have suggested the 
involvement of voltage-operated Ca2+ channels (VOCC), based on inhibitory effects of 
the L-type VOCC inhibitor, verapamil (Ortiz-Carranza and Czuprynski, 1992; Hsuan et 
al, 1998). However, these inhibitory effects have been observed at drug concentrations 
considerably higher than those required to inhibit Ca2+ flux in excitable cells, such as 
neurons and muscle cells, thus suggesting that verapamil may inhibit Ca2+ flux 
nonspecifically, by inhibiting receptor-operated Ca2+ channels (ROCC) or perhaps even 
by direct interaction with toxin-induced membrane pores. 
Therefore, the overall goal of this research project was to study the mechanisms 
involved in Hly A-induced increase in [Ca2+]i, including the involvement of VOCC and 
2 
ROCC in influx of extracellular Ca2+ and the contribution of Ca2+ released from 




Escherichia coli Alpha-Hemolysin - An RTX Toxin 
Certain strains of Escherichia coli secrete a cytolytic toxin known as HlyA. 
These E. coli strains were first identified by the presence of clear zones of beta hemolysis 
around colonies cultured on blood agar plates and production of a heat labile, filterable 
hemolytic substance by bacteria growing in liquid media (Lovell and Rees, 1969; 
Cavalieri and Snyder, 1982). Synthesized during exponential growth periods (Williams, 
1979), it is now believed that HlyA is a prominent virulence factor in human 
extraintestinal E. coli infections (Hacker et al, 1983; Knapp et al, 1986), especially 
pyelonephritis cases caused by uropathogenic E. coli (Laestadius et al, 2002). 
HlyA belongs to a family of RTX toxins (Repeats-In-IoKin) that increase the 
permeability of target cell plasma membranes to a variety of ions, causing target cell 
swelling and lysis (Jorgensen et al, 1983; Bhakdi et al, 1986; Welch et al, 1995). HlyA 
is considered the structural model for the RTX family of toxins. It has three functional 
domains that are conserved in sequence among other RTX members: a large 
hydrophobic, N-terminal domain; a region predicted to be ~-tum rich; and a carboxy-
terminal domain consisting of glycine-rich tandem repeats (Welch et al, 1995), the 
consensus sequence of which has repeating units represented by L-X-G-G-X-G-N-D-X 
(Boehm et al, 1990a). This 110 KDa protein exotoxin is encoded by the hlyCABD 
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genetic operon. The product of the hlyA structural gene is activated by HlyC and secreted 
extracellularly via the sec-independent pathway involving both HlyB and HlyD in 
conjunction with the downstream TolC gene product (Welch et al, 1995). 
Target Cell Specificity 
HlyA is capable of causing lysis of a broad range of target cell types from a 
variety of animal hosts (Cavalieri and Snyder, 1982) including sheep erythrocytes 
(sRBC), human granulocytes (Boehm et al, 1990b), and renal epithelial cells (Laestadius 
et al, 2002; Uhlen et al, 2000). This non-discriminating target cell specificity is in sharp 
contrast to the leukotoxin members of the RTX family (Welch et al, 1995). For example, 
Mannheimia haemolytica (previously, Pasteurella haemolytica) leukotoxin (LktA), 
demonstrates a very narrow target cell range, affecting only ruminant leukocytes and 
platelets (Kaehler et al, 1980). A recently discovered member of the RTX family, 
enterohemorrhagic E. coli toxin (Ehx), also has a relatively narrow target cell specificity, 
affecting only human, sheep, and bovine erythrocytes, but not human leukocyte-derived 
cell lines (Bauer and Welch, 1996). 
Effects on Target Cells 
Based on varying effects of HlyA on the integrity of target cells and their 
membranes, three types of actions have been recognized: subpermeabilizing, 
permeabilizing, and lytic actions (Welch et al, 1995). While these actions have been 
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considered to be toxin concentration-dependent, it is probable that the degree of cell 
damage caused by exposure to RTXtoxins is also incubation time-dependent (Clarke CR, 
personal communication). Therefore, depending on when HlyA-induced effects are 
measured, the same cells may first exhibit prelytic/sublytic responses and then undergo 
lysis as incubation time progresses. 
Sublytic/prelytic effects of Hly A have been studied in many different cell types, 
but especially in neutrophils. At low toxin doses, neutrophils exhibit a marked 
chemiluminescent response, indicative of an oxidative burst, along with decreased 
chemotaxis and phagocytosis (Cavalieri et al, 1984). Low-dose exposure causes the loss 
of ATP from neutrophils along with other intracellular constituents necessary for 
phagocytic function (Welch et al, 1995). These permeabilizing lesions formed prior to 
lysis apparently are not repaired by the cell, and intracellular concentrations of ATP 
never return to normal following HlyA challenge. Therefore, at low levels of exposure, it 
appears that HlyA impedes the primary host defense function of neutrophils without 
immediately lysing them, while at higher doses rapid cell lysis occurs (Bhakdi et al, 
1989). 
Other target cell types react similarly to Hly A exposure. Rat mast cells released 
histamine at toxin concentrations that were similar to those causing neutrophil 
chemiluminescence (Scheffer et al, 1985). When exposed to subpermeabilizing 
concentrations of HlyA, monocytes released measurable amounts of interleukin-I~ 
(Bhakdi et al, 1990). Sublytic effects of Hly A on renal proximal tubular cells included 
depletion of ATP stores and increased generation of superoxide radicals (Keane et al, 
1987). Endothelial cells were permeabilized at low concentrations of HlyA, allowing 
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passive influx of 45Ca2+ and production of prostacyclins from the arachidonic acid 
metabolic pathway in a Ca2+-dependent manner (Suttrop et al, 1990). 
Research conducted previously by Clarke and coworkers demonstrated that 
exposure of bovine neutrophils to M haemolytica LktA stimulated the release of 
eicosanoids, such as leukotriene B4 (LTB4): These studies implicated LTB4 as an 
important chemotactic agent for bovine neutrophils as well as a mediator of inflammation 
during M haemolytica infection (Wang et al, 1998; Cudd et al, 1999). Synthesis of 
L TB4 involves two key enzymes, phospholipase A2 (PLA2) and 5-lipoxygenase (5-LO). 
PLA2 catalyzes the hydrolysis of cell membrane phospholipids to liberate arachidonate, 
which then serves as a substrate for 5-LO - catalyzed synthesis of LTB4. In addition to 
generation of eicosanoid mediators, phospholipase action may contribute to LKT-induced 
loss of plasma membrane integrity via the formation of lysophospholipids. Wang et al, 
(1998) demonstrated conclusively, through studies using radiolabel release assays in 
conjunction with lactate dehydrogenase (LDH) leakage from exposed bovine neutrophils, 
that PLA2 was involved in LKT-induced synthesis of LTB4. This was shown to be a 
Ca2+-dependent action, as removal of Ca2+ from the incubation medium resulted in a 
decrease in radiolabel and LDH release (Wang et al, 1999). Ca2+-dependence was also 
demonstrated by using the Ca2+-specific chelator EGTA. LKT-induced effects were 
restored when the Ca2+ concentration exceeded the chelating capacity of the EGT A 
present in the media. 
Depending on the proximity of phagocytes to infecting organisms and the 
duration of infection, a range of RTX toxin-induced responses can be expected to occur 
in vivo. For example, neutrophils initially responding to an infection involving a RTX-
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producing bacterium would be primed for respiratory burst activity. As neutrophils 
migrated closer to the site of infection, they would be exposed to higher permeabilizing 
concentrations of HlyA, causing influx of extracellular Ca2+, stimulation of signal 
transduction pathways, and premature degranulation. Neutrophils located at the site of 
infection would be exposed to very high concentrations of toxin, which would cause 
serious impairment of their host defense capability and lysis (Welch et al, 1995). 
Interaction of Hly A with Target Cell Membranes 
Hly A has been demonstrated through immunological studies to be associated with 
the membranes of its target cells (Bhakdi et al, 1986; Bhakdi et al, 1989; Eberspacher et 
al, 1989), where it acts to increase the cation permeabilities of whole cells, such as 
erythrocytes, and artificial lipid bilayers (Boehm et al, 1990b; Jorgensen et al, 1983). 
Earlier studies, particularly those employing erythrocytes and artificial lipid bilayers, 
suggested that HlyA integrates into the plasma membrane to form transmembrane pores. 
Evidence for Formation of Transmembrane Pores 
Insertion of the N-terminal hydrophobic region of Hly A into a target cell plasma 
membrane has been postulated by a number of researchers to create a transmembrane 
pore capable of conducting ions (Figure 1 ). This toxin-induced ion channel is believed to 
consist of eight membrane-spanning alpha-helical runs per toxin molecule, based on 
computer models capable of predicting secondary protein structure based on amino acid 
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sequence. In support of this theory, Ludwig et al (1991) reported that amino acid 
substitutions in the N-terminal hydrophobic region resulted in a loss of hemolytic activity 
and that non-hemolytic isolates had mutations in this region. Interaction of HlyA with 
target membranes apparently is facilitated also by acylation of the protein, an activation 
step accomplished by LktC (Wagner et al, 1983; Welch et al, 1995; Rowe et al, 1994), 
and by the nine amino acid repeat region located immediately proximal to the export 
signal at the carboxyl terminus of the protein (Rowe et al, 1994; Welch 1995). 
Irrespective of the length of this region, which varies in the number of repeats among 
RTX family members (Lo et al, 1987), it has been shown to be essential for hemolytic 
activity (Felmlee et al, 1985). The principal function of the repeat region is to bind Ca2+, 
presumably prior to export from the bacterial cell (Boehm et al, 1990a; Boehm et al, 
1990b). Deletion of gene sequences encoding for this repeat region results in the 
production and export of a toxin that is non-hemolytic and incapable of associating with 
erythrocyte membranes (Ludwig et al, 1991). 
Based on the observation that HlyA aggregates in solution, Ostolaza et al (1991) 
proposed that creation of a membrane pore involved integration and organization of the 
toxin into the membrane in the form of an oligomer, such as occurs with many gram-
positive cytolysins (Bhakdi and Tranum-Jensen, 1986; Bhakdi and Tranum-Jensen, 
1988). However, attempts to physically isolate an assembled HlyA oligomer by 
solubilizing toxin-treated membranes with deoxycholate, followed by sucrose-density 
gradient centrifugation and SOS-PAGE analysis, were unsuccessful (Bhakdi et al, 1986). 
Similar approaches had been successful in identifying stable oligomers of Staphylococcus 
aureus a-toxin (Bhakdi et al, 1981 ). Thus, it was proposed that IDy A integrates into the 
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plasma membrane in the form of a monomer (Boehm et al, 1990b), forming a functional 
pore with an estimated diameter of 1-3 nm (Benz et al, 1989; Menestrina et al, 1987). 
Evidence in support of Hly A monomers forming transmembrane pores is based 
principally on experiments conducted using planar lipid bilayers and erythrocytes. When 
added to lipid bilayers, HlyA monomers formed water-filled transmembrane pores in a 
voltage-dependent process (Menestrina et al, 1987). The properties of these pores were 
shown quantitatively to account for the observed effects ofHlyA on erythrocytes. 
Theories involving toxin-induced pore formation are consistent with the results of 
osmotic protection studies (Bhakdi et al, 1986; Clinkenbeard et al, 1989; Iwase et al, 
1990; Ehrmann et al, 1991), the theoretical premise of which is that extracellular solutes 
with molecular diameters larger than the size of a pore formed in the target cell 
membrane will prevent oncotic lysis of target cells. Utilizing moderate to high molecular 
weight sugars as osmotic protectants, Bhakdi et al (1986) postulated the existence of 
pores in the form of protein lined, static-sized channels with diameters of approximately 
3 nm, based on the observation that dextran-4 protected erythrocytes from hemolysis 
after 45 minutes of RBC exposure. 
However, studies conducted by Moayeri and Welch (1994) indicated that osmotic 
protection, as a means of lesion size determination, was sensitive to environmental 
factors such as temperature, Hly A concentration, and incubation time, thus suggesting 
that membrane permeability may be related to a dynamic phenomenon more consistent 
with loss of membrane integrity due to the action of enzymes or a detergent effect of 
Hly A. Indeed, Ostolaza et al (1993) proposed that leakage of ions and diffusion of water 
across toxin-exposed membranes did not occur via toxin-formed pores but as a result of 
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detergent effects of IDy A on the membrane. These and other studies employing lipid 
bilayers concluded that the interactions between RTX toxins and target cell membranes 
were fairly nonspecific in nature and did not involve specific binding to membrane 
receptors, an interpretation that largely has been refuted by subsequent and more recent 
studies described below. 
Involvement of Cell Membrane Receptors and Other Proteins in Binding of R TX Toxins 
Interaction of RTX toxins with target cell membranes appears to be mediated by 
binding to specific cell surface receptors (Bhakdi et al, 1989), although, as described 
above, there is evidence that these toxins may disrupt the integrity of protein-free 
liposomes and planar lipid bilayers (Bhakdi et al, 1988), thus suggesting the possibility of 
non specific toxin-membrane interactions. The probable involvement of membrane 
surface receptors provides a rational explanation for the target cell specificities of RTX 
toxins. HlyA is active against an exceptionally broad range of target cells, including both 
human and animal leukocytes and erythrocytes. This non-discriminating target cell 
specificity is in sharp contrast to the leukotoxin members of the RTX family, which are 
capable only of causing lysis of relatively few target cell types, including leukocytes and 
platelets (Welch et al, 1995). However, despite the wide target cell specificity of HlyA, 
thus suggesting the absence of specific toxin-membrane interaction, Lally et al (1997) 
reported compelling evidence indicating that interaction with HL60 cells is mediated by 
specific binding to ~2 integrins, which serve as cell membrane surface receptors. HlyA-
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induced lysis could be inhibited by monoclonal antibodies to aCD1 la and aCD18, which 
constitute the LFA-1 receptor, a member of the ~2 integrin family. 
There is evidence even that exposure to Hly A may cause subpermeabilizing 
effects on neutrophils that may not be related directly to integration of a-helical regions 
of the molecule into the cell membrane. Apparently, these effects are mediated by 
binding to cell surface receptors and activation of intracellular signal transduction 
pathways (Bhakdi et al, 1988). For example, HlyA has been shown to induce 
phosphoinositol turnover. Furthermore, the effects of HlyA can be inhibited by 
Bordatella pertusis toxin, which causes long-lasting activation of the G-inhibitory protein 
(Gi) for adenylate cyclase (Welch et al, 1995; Sperelakis, 1998). Gi involvement 
suggests G-protein linked receptor activation and stimulation of signal transduction 
pathways associated with leukotriene formation and oxidative burst (Grimminger et al, 
1991a). 
Effects of HlyA on ion permeability of Target Membranes 
Bhakdi et al (1986) originally hypothesized that the membrane lesions produced 
by HlyA served as cation-selective channels. Based on this study, as well as the research 
conducted by Jorgensen et al (1983), which demonstrated a rapid efflux of cellular K+ 
and influx of 45Ca2+ preceding Hly A-induced hemolysis, cell damage and hemolysis was 
hypothesized to result from selective Ca2+ uptake (Bhakdi et al, 1986). Reports 
indicating that extracellular Ca2+ was required for induction of hemolysis by Hly A 
(Cavalieri et al, 1984) appeared to be compatible with this proposed hypothesis, which 
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was also supported by experiments conducted by Boehm et al (1990b), suggesting that 
lysis of target cells was the result of cation influx/efflux followed by influx of water due 
to the disruption of membrane integrity. 
Experiments employing artificial lipid bilayers indicated that HlyA caused single 
channel conductance changes characterized by nonlinear dependence of membrane 
conductance on IIlyA concentration over time (Benz et al; 1989). Other planar-lipid 
bilayer experiments described a linear dependence of membrane conductance on toxin 
concentration. These HlyA-mediated ion channels in planar lipid bilayers had limited 
longevity and displayed rapid switching between the open/closed states (Benz et al 
1989). 
Observations relating to single-channel conductance of artificial lipid bilayers are 
compatible with the osmotic lysis noted in erythrocytes following rapid K+ efflux 
(Menestrina et al, 1987). Changes in conductance were voltage-dependent and 
proportional to the conductivity of the media. These cation-selective channels opened at 
a rate that was exponentially proportional to the applied voltage (Menestrina et al, 1987). 
Clinkenbeard et al (1989) concluded that M haemolytica LktA creates pores in the 
plasma membranes of bovine BL3 cells that allow leakage of intracellular K+ within 
minutes of exposure, but that larger cytosolic proteins were retained by the cell. This 
phenomenon was referred to as toxin-induced molecular sieving, which causes a relative 
increase in the intracellular osmotic pressure, resulting in cell swelling (Clinkenbeard et 
al, 1989). Following cell swelling, further membrane damage resulted in leakage of 
larger cytosolic components. 
13 
Intracellular Calcium Signaling 
Calcium as a Second Messenger 
Calcium has long been recognized as an essential mediator of many cellular 
functions, including fertilization, development, differentiation, adhesion, growth, 
division, movement, contraction, and secretion. Clearly, Ca2+ plays a very versatile role 
in many biological systems, including mechanisms of action of bacterial toxins (Cudd et 
al, 1999). Investigating the involvement of Ca2+ in RTX toxin-induced effects on target 
cells has required use of a variety of technical approaches, including alteration of 
extracellular Ca2+ concentration using chelators and use of pharmacological agents that 
specifically stimulate or inhibit Ca2+ homeostatic mechanisms. Pharmacological agents 
used include those that interact with specific types of Ca2+ channels to inhibit 
conductance (e.g., LaCh, verapamil), those that chelate Ca2+ (e.g., EGTA), or those that 
serve as ionophores to promote flux of Ca2+ across cell membranes ( e.g., A23187). Other 
agents used include those that specifically inhibit or promote uptake or release of Ca2+ 
from intracellular stores (e.g., Mg2+, xestospongin C, thapsigargin). 
Changes in [Ca2+]i, which constitute an important signal transduction pathway for 
many different cell responses, typically result from opening of Ca2+ channels or activity 
of Ca2+ transporters (Berridge et al, 1998). These are localized either in the plasma 
membrane, or inside the cell in membranes of various organelles, especially the 
sarcoplasmic/endoplasmic reticulum (ER). Plasma membrane Ca2+ channels are 
differentiated according to their activation mechanism and include voltage-operated, 
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receptor-operated, and mechanically activated Ca2+ channels, as well as store-operated 
Ca2+ channels, which open in response to depletion of internal Ca2+ stores (Berridge et al, 
1998). Ca2+ release from ER stores occurs via inositol 1,4,5-triphosphate (IP3) receptors 
and ryanodine (Ry) receptors. Another less characterized channel known as the 
sphingolipid Ca2+-release-mediating protein of ER (SCaMPER) is reported to release 
Ca2+ in response to an increase in sphingolipid concentrations. The differential 
expression of these channels provides cells with alternative strategies for responding to a 
diverse range of stimuli, thus producing Ca2+ signals that are tissue-specific (Berridge et 
al, 1998). When activated, both Ca2+-entry and Ca2+-release channels respond for a short 
time only to produce brief and well-controlled pulses of Ca2+ that create localized 
increases in [Ca2+]. These events have been visualized by confocal microscopy 
techniques in living cells (Lipp and Niggli, 1997) and have a limited spatial range 
estimated to be 1-6 µm, with the [Ca2+] declining rapidly as the distance from the site of 
the channel increases. Regulation of cellular activities relies on close proximity of the 
Ca2+ channels to their effector mechanisms, allowing changes in [Ca2+]i to have highly 
specific effects (Bootman and Berridge, 1995). 
Release of Ca2+ from Intracellular Stores 
In a normal resting state, cells utilize ATP-driven Ca2+ pumps to maintain low 
[Ca2+]i of 100 nM or less. These pumps establish a steep [Ca2+] gradient between the 
cytosol and the extracellular environment as well as the intracellular stores (da Silva 
2000). Three intracellular receptor-mediated pathways are responsible primarily for 
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mobilizing Ca2+ stores: those activated by IP3 (Streb et al, 1983), cyclic adenosine 
diphosphoribose ( cADPR), or nicotinic acid adenine dinucleotide phosphate (NAADP+), 
initially described by Lee and coworkers (Lee, 1997, Lee et al, 1989). IP3 and cADPR 
act as second messengers and endogenous ligands of the IP3 and ryanodine (Ry) 
receptors, respectively. It has been demonstrated that the intracellular concentrations of 
IP3 and cADPR increase upon stimulation of receptors on the plasma membrane, but 
similar results have not yet been reported for NAADP+ (da Silva et al, 2000). The IP3 
and cADPR systems are highly conserved (Lee, 1997), perhaps because it is irrelevant to 
the cell which of the three Ca2+-mobilizing system is activated when a global Ca2+ 
response is required. However, it is possible also that these apparently redundant 
mechanisms may act independently to produce localized changes in [Ca2+]i that differ in 
amplitude and duration, thus producing finely tuned physiological responses. 
Under resting conditions, the intracellular [IP3] is kept relatively low, but levels 
increase rapidly following stimulation of cell surface receptors and subsequent activation 
of the enzyme, phospholipase C (PLC), by G-proteins or by receptor., and non receptor-
associated tyrosine kinases (Berridge, 1993). Activated PLC catalyzes the hydrolysis of 
membrane phosphatidylinositol 4,5-bisphosphate to produce two secondary messengers, 
IP3 and 1,2-diacylglycerol (da Silva et al, 2000). Pharmacological tools available to 
study IP3-mediated Ca2+ release include compounds such as heparin and xestospongin C, 
which are potent and specific antagonists ofthe lP3 receptor (IP3-R) (Gafni et al, 1997). 
cADPR is a cyclic derivative of ~-nicotinamide adenine dinucleotide, which is 
synthesized by ADP-ribosyl cyclase (Lee et al, 1989). Occurring in both membrane-
bound and soluble forms, cADPR mediates Ca2+ release by binding to Ry receptors (Ry-
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R), historically identified with mechanisms of Ca2+ -induced Ca2+ release (CICR) 
(Fabiato, 1983). Three isoforms of Ry-R have been identified and specific stimulatory 
effects of cADPR on Ry-R subisotypes 2 and 3 have been demonstrated (Meszaros et al, 
1993). Pharmacological studies have confirmed that cADPR is a physiological 
modulator of CICR (Galione, 1992) and that cADPR stimulation of the Ry-R/Ca2+ 
channel is promoted by Ca2+, calmodulin, inorganic phosphate, and palmitoyl-CoA, and 
inhibited by high concentrations of Mg2+ (Lee, 1997; and Guse et al, 1996). 
Pharmacological tools used to study cADPR-mediated Ca2+ release include Ry and 
caffeine, which activate Ry-R, and ruthenium red, procaine, and various synthetic 
derivatives of cADPR, such as 7-deaza-8-Br-cADPR, which inhibit Ry-R (Guse, 2000). 
The ionic conductance of Ry-R generally is similar to that reported for the IP3-R 
(Bezprozvanny and Erlich, 1994). 
In contrast to the IP3- and cADPR-mediated signaling pathways, many aspects of 
NAADP+-mediated Ca2+ signaling are still unknown. For example, neither the identity of 
the enzyme involved in intracellular synthesis of NAADP+ nor the intracellular receptor 
of NAADP+ has been identified ( da Silva et al, 2000). 
Influx of Ca2+ Across the Plasma Membrane 
A variety of channels in the plasma membrane have been identified that have 
specific conductances to Ca2+. Depending on whether the conductances change in 
response to transmembrane voltage or to binding of specific ligands, they are broadly 
classified as voltage-operated Ca2+ channels (VOCC) or receptor-operated Ca2+ channels 
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(ROCC) (Tsein and Tsein, 1990; Spedding and Paoletti, 1992; Berridge, 1997). VOCC 
usually require steep membrane depolarization for activation, exhibit high-affinity 
conductance of Ca2+, and can be selectively modulated by neurotransmitters, G-proteins, 
and diffusible messengers (Tsein and Tsein, 1990). Subclassifications of VOCC include 
L-type channels that are activated by high voltage and inhibited by dihydropyridine 
antagonists, T-type channels that are low-voltage operated and inhibited by low 
extracellular Ni2+ concentration, N-type channels that are high voltage activated and 
inhibited by m-conotoxin, and P-type channels that are moderately high-voltage activated 
but not inhibited by dihydropyridine antagonists or m-conotoxin (Tsein and Tsein, 1990). 
ROCC open in direct response to binding of a ligand (Tsein and Tsein, 1990), 
although the function of these may also be dependent on changes in membrane potential. 
Nonspecific antagonism of ROCC can be accomplished using large trivalent cations, such 
as La3+, which competes with Ca2+ for binding to channel proteins without being 
transported through the channel (Thomson and Dryden, 1981; Gould et al, 1982; Rosales 
and Brown, 1992). LaCh has been shown to completely block Ca2+ entry in human 
neutrophils expo·sed to fMLP, an activator of ROCC, while VOCC blockers had no 
effects on Ca2+ entry into the cell (Rosales and Brown, 1992). 
In a variety of cell types, release of Ca2+ from intracellular stores and depletion of 
these stores triggers influx of Ca2+ into the cell via Ca2+ channels in the plasma 
membrane, a process termed capacitative Ca2+ entry (CCE) (Putney, 1986; Putney, 2001). 
Hoth and Penner (1992) measured the Ca2+ current associated with store depletion and 
termed it Ca2+ release-activated Ca2+ current (IcRAc). This IcRAc pathway has been 
characterized as one of relatively low conductance (Zweifach et al, 1993) and susceptible 
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to bivalent and trivalent cation blockers, such as Ni2+ and La3+. However, lcRAc 
pathways were shown to be insensitive to L-type and N-type Ca2+-channel blockers (Yao 
et al, 1994). Studies employing a Drosophila model suggested that the transient receptor 
potential (trp) gene product may function as a CCE channel (Friel, 1996; Putney et al, 
2001). Over-expression of Trp has been shown to augment CCE (Kiselyov et al, 1998; 
Liu et al, 2000). Furthermore, there is general agreement from several studies that Trp3 
and other closely related membrane proteins can be activated in an IP3- and IP3-R-
dependent manner (Putney et al, 2001 ). 
CCE has subsequently been confirmed to occur in numerous cell types, but 
mainiy in non-excitable cell types such as endothelial, epithelial, and blood cells (Holda 
and Blatter, 1997; Putney, 2001). Recent evidence indicates that CCE plays an important 
role in many aspects of cellular Ca2+ signaling, such as volume regulation, mitogenesis, 
regulation of adenylate cyclase, and sustained Ca2+ oscillations (Berridge, 1995). 
Although the universal importance of CCE is generally recognized, until recently no 
consensus had been reached concerning the specific cellular mechanisms involved in this 
pathway. Several hypotheses have evolved to explain the mechanism of CCE (Putney 
and Bird, 1993; Clapham, 1995; Berridge, 1995) and these can be classified according to 
two proposed mechanisms for the retrograde Ca2+ entry signal: (1) Release of a 
diffusible second messenger, termed calcium influx factor (CJF), that is produced when 
Ca2+ stores become depleted and that stimulates Ca2+ influx across the plasma membrane. 
(2) Depletion of stored Ca2+ causes conformational changes that bring ER receptors into 
close proximity with plasma membrane receptors. To date, specific and direct 
pharmacological activators of CCE have not been identified. However, there are 
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pharmacological agents that will activate this pathway by virtue of their ability to deplete 
intracellular Ca2+ stores (Putney et al, 2001), such as thapsigargin, which inhibits uptake 
of Ca2+ by the smooth endoplasmic reticulum Ca2+ ATPase (SERCA) pump (Putney, 
2001). 
Mechanisms ofHlyA-Induced Increase [Ca2+]; in 
Most studies investigating the effects of Illy A on target cells have indicated that 
extracellular Ca2+ is necessary for induction of toxicity and that many of these effects can 
be mimicked using calcium ionophores, such as A23187. In experiments involving in 
vitro exposure of renal epithelial cells to Illy A, the toxin induced constant, low-frequency 
oscillations in [Ca2+]i that could be inhibited by nifedipine, an L-type VOCC inhibitor 
(Uhlen et al, 2000). Furthermore, nifedipine and verapamil, another VOCC inhibitor, 
have been reported to inhibit increase in [Ca2+]i in LktA-exposed bovine neutrophils 
(Ortiz-Carranza and Czuprynski, 1992; Hsuan et al, 1998). These experiments suggest 
that the increase in [Ca2+]i induced by RTX toxins occurs by influx of Ca2+ via VOCC in 
the plasma membrane, presumably in response to a change in transmembrane potential. 
However, conclusions based on these studies suggesting the involvement of VOCC may 
not be correct because of the high concentrations ofVOCC inhibitors required to produce 
inhibitory effects, relative to the concentrations required to inhibit excitable cells, such as 
neurons. Indeed, it is possible that these blockers may be acting on VOCC located on 
intracellular vesicular membranes or that they may be exerting nonspecific inhibitory 
effects on RTX toxin-induced transmembrane pores. 
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There is evidence that not all HlyA-induced effects are entirely dependent on 
influx of extracellular Ca2+, but that release of intracellular, stored Ca2+ may also be 
involved. For example, Grimminger et al (1991b) suggested that that the marked 
capacity of low doses of HlyA to induce degranulation, respiratory burst, and lipid 
mediator generation in human neutrophils probably involved signal transduction 
mediated by products of phophatidyl inositol hydrolysis, which stimulate release of 
stored Ca2+ via the IP3-R. Furthermore, Uhlen et al (2000) reported that HlyA-induced 
oscillations in [Ca2+Ji of renal epithelial cells could be inhibited by 2-
aminoethoxydiphenyl borate, an lP3-R antagonist and that inhibition of PLC, the enzyme 
that produces IP3, caused a similar effect. These studies suggest that HlyA-induced 
increase in [Ca2+Ji may result from a combination of mechanisms involving both influx 
of extracellular Ca2+ across the plasma membrane and release of Ca2+ from intracellular 
stores. Considering the relevance of [Ca2+Ji to effects of HlyA on target cell structure 
and function, these mechanisms need to be specifically elucidated before 
pharmacological inhibitors can be developed to protect cells against the pathogenic 
effects ofRTX toxins. 
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€3: 13 tandem repeats 
Active HlyA 
Figure 1. HlyA is postulated to associate with HL60 and other target cell membranes in a 
calcium-dependent manner. Amino acid analyses (Felmlee, 1985) suggests 
that N-terminal phobic runs integrate into the outer leaflet of the plasma 
membrane. Other HlyA structures include J3-barrel and Ca2+ -binding 
domains. Binding to Ca2+ depends on the carboxy-terminal tandem repeats 
that are characteristic of the RTX toxin family. Figure adapted from Forestier 
and Welch, 1991. 
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CHAPTER III 
HYPOTHESIS AND EXPERIMENT AL OBJECTIVES 
Phase I 
Previous studies conducted by Cudd et al (1999) and others (Ortiz-Carranza et al, 
1992) reported inhibitory effects of VOCC blockers on both RTX toxin-induced increase 
in [Ca2+]i and subsequent release ofLTB4, thus suggesting that influx of Ca2+ via VOCC 
may be an important event in the molecular pathogenesis of Hly A. Based on these 
observations, the initial hypothesis upon which this research was based was that increase 
in [Ca2+]i induced by HlyA was caused by influx of extracellular Ca2+ through VOCC in 
the plasma membrane and that opening of these VOCC occurred in response to changes 
in membrane potential following HlyA-induced influx of monovalent cations (Figure 2). 
This hypothesis was tested by measuring the effect of Hly A on [Ca2+]i, [Na +]i, and 
membrane potential of individual and suspended populations of HL60 cells, using 
fluorescent indicators, and the ability of verapamil, a VOCC blocker, to inhibit any 
HlyA-induced responses. To eliminate the potential contribution of other virulence 
factors produced by E. coli, such as LPS, effects of Hly A were compared to those 
produced by an HlyA-deficient mutant strain of E.coli. 
Specific Phase I experimental objectives (addressed in Chapter IV) were to: 
(1) prepare HlyA and negative toxin controls from strains W AM 582, W AM 783 and 
W AM 971, develop methods for the assay of toxin activity, and assess Hly A storage 
stability; 
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(2) confirm that exposure ofHL60 cells to IIlyA caused increased [Ca2+]i; 
(3) investigate the effects oflilyA exposure on [Na+]i; 
(4) determine whether exposure to IIlyA caused changes in plasma membrane voltage 
potential; and 
(5) determine whether any HlyA-induced increase in [Ca2+]i and/or [Na+]i could be 
inhibited by the VOCC blocker, verapamil. 
Phase II 
While the results of the studies conducted in Phase I confirmed that exposure of 
HL60 cells to HlyA caused changes in [Ca2+]i and [Na+]i, it was clear that these effects 
were not associated with changes in membrane potential or exclusive involvement of 
VOCC. Based on further studies that implicated receptor-operated Ca2+ entry, the initial 
Phase I hypothesis was rejected in favor of an alternate hypothesis that Illy A-induced 
increase in [Ca2+]i is not caused by voltage-dependent mechanisms but is caused instead 
by receptor-operated influx of extracellular Ca2+ through the plasma membrane and by 
release of Ca2+ from intracellular stores. 
This alternate hypothesis was tested by investigating the affects of 
pharmacological inhibitors of Ca2+ transport across the plasma membrane and the 
membranes of intracellular storage vesicles, and by comparing the effects of Illy A on 
HL60 cells with similar cells (K562 cells) that do not express relevant cell surface 
receptors. 
Specific Phase I experimental objectives (addressed in Chapter V) were to: 
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(1) explore the involvement ofROCC in IIlyA challenge; 
(2) investigate whether release of intracellular Ca2+ stores and capacitative Ca2+ entry 
contribute to Illy A-induced changes in [Ca2li; and 
(3) determine whether HlyA binding to surface-expressed j32 integrin receptors is 





Figure 2. Initial hypothesis describing formation of a transmembrane pore by insertion of 
hydrophobic N-terminal amino acids into the plasma membrane. Flux of 
monovalent cations through this toxin-induced pore was postulated to cause 
changes in transmembrane potential that stimulated opening of VOCC and 
influx of extracellular Ca2+. 
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CHAPTER IV 
ROLE OF VOLTAGE-OPERATED CALCIUM CHANNELS IN ESCHERICHIA COU 
ALPHA HEMOL YSIN-INDUCED INCREASE IN INTRACELLULAR CALCIUM 
CONCENTRATION OF HL60 CELLS 
Introduction 
Escherichia coli normally represents a major component of the intestinal flora in 
humans, but some strains may colonize and infect extra-intestinal sites, such as the 
urinary tract. In particular, strains producing IIlyA can cause severe damage to the 
kidneys, resulting in permanent scarring and loss of function (Laestadius et al, 2002). 
Other Illy A-related illnesses include peritonitis and meningitis (Menestrina et al, 1994). 
HlyA is a: member of the family of RTX toxins, characterized by amino acid 
glycine-rich tandem repeats proximal to the carboxyl terminus of these proteins (Bohach 
et al, 1988). Hemolytic and/or cytotoxic effects of RTX toxins on mammalian target 
cells are Ca2+ -dependent (Boehm et al, 1990), as evidenced by the requirement that Ca2+ 
be bound to the toxin molecule for full expression of activity and the role of increased 
[Ca21i in mediating effects on target cells, including renal epithelial cells and leukocytes 
(Uhlen et al, 2000; Grimminger et al, 1991b). 
Previous studies reported that inhibitors of VOCC inhibited increase in [Ca2+]i in 
renal epithelial cells exposed to HlyA and in neutrophils exposed to another RTX toxin, 
Mannheimia haemolytica LktA. These observations suggest that increase in [Ca2+]i is 
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caused by influx of extracellular Ca2+ through VOCC in the plasma membranes of target 
cells, presumably in conjunction with a change in membrane potential caused by 
transmembrane flux of monovalent ions, such as Na+. However, this proposed 
involvement of VOCC in RTX-toxin induced increase in [Ca2+Ji may not be correct 
because high concentrations of VOCC inhibitors generally are required to produce 
inhibitory effects (compared with the concentrations required to inhibit excitable cells, 
such as neurons) and the lack of credible evidence indicating that VOCC even exist in 
non-excitable neutrophils (von Tscharner et al, 1986). It is possible that VOCC 
inhibitors may be exerting nonspecific inhibitory effects on RTX toxin-induced 
transmembrane pores, thus limiting the potential use of these agents in the therapy of 
RTX toxin-mediated diseases. 
Therefore, the objectives of this phase of study were to: (1) develop methods for 
preparation, assay, and storage of HlyA and negative toxin controls; (2) confirm that 
exposure of HL60 cells to HlyA caused increased [Ca2+]i; (3) investigate the effects of 
HlyA exposure on the monovalent ion, [Na+]i; (4) determine whether exposure to HlyA 
caused changes in plasma membrane voltage potential; and (5) determine whether any 
HlyA-induced increase in [Ca2+]i and/or [Na+]i could be inhibited by VOCC inhibitors. 
Materials and Methods 
Preparation of E. coli HlyA 
Hly A and Hly Ac- negative control were prepared by harvesting culture 
supernatants from Escherichia coli host DHl (Forrestier et al, 1991) expressing 
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hlyCABD (W AM 582) and hlyABD (W AM 783) genes, respectively. In contrast to 
W AM 582, which produced the active 110 kDa toxin protein (Rowe et al, 1994), W AM 
783 produced a nonacylated inactive form of the toxin. Another control strain, W AM 
971, contained only the plasmid used as a vector during transfection. 
Bacterial strains were cultured on Luria agar (Sigma Chemical Co.) and selected 
on the basis of resistance to 20 µg/ml chloramphenicol (Cm). Isolated colonies were then 
cultured in 10 ml Luria Broth (LB) base and 20 µg/ml cm overnight at 37°C at 160 
oscillations/minute. These cultures were expanded into 1 LLB containing 20 µg/ml cm 
with shaking (160 osc/min.) and grown to an optical density (OD600) of 0.85. Preliminary 
studies revealed that the bacterial strains grew exponentially after an initial 2-hour lag 
period (Figure 3) and that production of Illy A (as measured by lytic activity) occurred in 
parallel with bacterial replication. Maximal production of active IDy A was achieved 
after 7 hours of incubation. 
Further preparation of toxin was conducted at 4°C. Culture supematants were 
collected following centrifugation at 8,000 rpm for 30 minutes (Sorvall RC 5B Plus using 
Superlite GS-3 rotor by DuPont) and concentrated by addition of ammonium sulfate (361 
g/1) with gentle stirring for one hour to yield 60% saturation. The precipitated material 
was collected by centrifugation at 8,500 rpm for 45 minutes (Sorvall RC 5B Plus, using 
Superlite GS-3 rotor by DuPont), resuspended in 5 ml phosphate buffered saline (PBS), 
and dialyzed for 4 hours against l liter of PBS for x3 buffer changes. Dialyzed, 
concentrated culture supematants were aliquoted and stored frozen at-135°C until used. 
The purity of toxin preparations was assessed by SDS-PAGE. Briefly, toxin 
preparations were mixed 1 :2 in SDS-PAGE sample buffer (Sigma Chemical Co.) and 
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boiled for 5 min. Samples were subjected to SDS-PAGE on 10% gels, which were then 
silver stained (Daiichi Silver Stain II, Integrated Separation Systems). Preparations 
produced multi-banded lanes (Figure 4), consistent with the multimeric protein 
aggregates demonstrated in previous studies (Ostolaza et al, 1991). 
Assay of HlyA activity 
Prior to freezing, baseline lytic activity of each HlyA preparation was assessed 
usmg sheep erythrocytes (sRBC) and HL60 cells, by measuring the release of 
hemoglobin (Hb) and lactate dehydrogenase (LDH), respectively, after exposure to HlyA 
or toxin controls (Figure 5). Lysis of sRBC represents a common method of estimating 
HlyA activity and served as a basis for comparison with other published reports. Lysis of 
HL60 cells provided a measure of activity that was directly relevant to the present study 
and was necessary to calculate appropriate dilutions of toxin in each of the experiments. 
HL60 lytic activity of thawed samples was assessed on a weekly basis to ensure that 
HlyA preparations used in experiments were at least 70% of initial activity. 
Target cells were exposed to Hly A and control preparations in 96-well round 
bottom microtiter plates by serial dilution in assay buffer (pH 7.2, 1 mM CaCh in 
modified Hank's Buffered Saline Solution [HBSS], Sigma Chemical Co.) to a total 
volume of 150 µI. Target cells (100 µl of either 1% (v/v) sRBC or 4x104/ml HL60) were 
added to all wells and the plates were incubated at 37°C for 1 hour. Toxic exposure was 
terminated by centrifugation (7 min at 700 x g) and 100 µI of assay supernatant was 
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transferred to a flat-bottom 96-well plate in order to determine the amount of Hb or LOH 
release. 
Hb concentration in supematants was determined at room temperature using a 
plate reader (ThermoMax, Molecular Devices) set at OD550 . Maximal Hb leakage was 
achieved by replacing HlyA with 50 µL of 0.01% saponin solution (Sigma Chemical 
Co.). Background absorbance was determined by replacing HlyA with 100 µl assay 
buffer. Likewise, the amount ofLDH released was determined at 37°C using a thermally 
controlled microtiter plate reader at 00340 (ThermoMax, Molecular Devices), as 
previously described (Clinkenbeard et al, 1994). Percent specific release of either Hb or 
LOH was calculated using the following equation: 
% Specific release= 100 x (A-B)/(C-B) 
where A, B, and C are the toxin-induced release, background absorbance, and maximum 
release values, respectively. HlyA activity was expressed as toxic units (TU), where 1 
TU was defined as the dilution of Hly A required to cause 50% maximal release. 
Comparison between% specific release of Hb and LOH from sRBC and HL60 cells, 
respectively, revealed that sRBC were more sensitive to the effects of HlyA, suggesting 
that the mechanisms of intoxication may differ between these two cell types (Figure 5). 
Alpha hemolysin storage and optimization studies 
Preliminary experiments were conducted to estimate the time course of HL60 cell 
intoxication and to determine the stability of toxin preparations under storage conditions. 
31 
Measurement of% specific release of LDH from HL60 cells exposed to 5 TU/ml Hly A 
before and after 15, 30, 60, 90 and 120 minutes of incubation at 37°C indicated that 
maximum release was achieved between 60 - 90 minutes (Figure 6). 
Stability of frozen HlyA was investigated by measuring the% specific release of 
LDH after 4, 6, 8, 14, 21 and 25 days of storage at -135°C. Although activity declined as 
storage time increased, a predictable relationship between these variables could not be 
established, thus necessitating performance of LH60 activity assays immediately prior to 
conducting each set of experiments. 
Preparation of HL60 cells 
HL60 cells were obtained from American Type Cell Culture (ATCC) and cultured 
in Dulbecco's Modified Eagles Medium (DMEM) with 10% FBS (pH 7.1) in an 
incubator at 37°C and 5% CO2. Harvested cells were resuspended in HBSS containing 1 
mM Ca2+ (Ca-HBSS, pH 7.1), washed x3 in 50 ml of Ca-HBSS by centrifugation at 
1,082 x g, and then resuspended in 10 ml Ca-HBSS at a concentration of 4.8 x 106/ml, as 
determined by hemocytometer. 
Measurement of intracellular cation concentrations in isolated single cells 
Intracellular concentrations of Ca2+ and Na+ in single isolated cells were measured 
using the ratiometric fluorescent indicators, Fura-2 and Sodium Benzofuran Isophthalate 
(SBFI), respectively. For [Ca2+]i determination, HL60 cells suspended in Ca-HBSS in a 
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light-tight 50 ml culture tube were incubated at room temperature for 30 minutes with 5 
µM Fura-2 (Molecular Probes). Loading of fluorescent indicator was terminated by 
centrifugation (10 minutes at 200 x g) and loaded cells were washed twice in 50 ml Ca-
HBSS and then resuspended to a final volume of 10 ml. 
For [Na +]i determination (Harootunian et al, 1989), HL60 cells were suspended in 
10 ml of 10 mM HEPES buffered DMEM (pH 7 .1, 4.8 x 106 cells/ml) in a light-tight 50 
ml culture tube, which was incubated for 45 minutes with 5 µM SBFI (Molecular Probes) 
at 37°C (5% CO2). Loading of fluorescent indicator was terminated by centrifugation (10 
minutes at 250 x g) and loaded cells were washed twice in 50 ml of 10 mM HEPES 
buffered DMEM and then resuspended in 10 ml of 150 mM Na+-HEPES (130 mM Na-
Gluconate, 30 mM NaCl, 10 mM HEPES, 1 mM CaCb, 1 mM MgS04, pH adjusted to 
7.1 with n-methyl-glucamine). Depending on the experimental requirements, cells were 
suspended in 150 mM K+-HEPES for experiments requiring absence of Na+ or mixed in 
different ratios with 150 mM Na +-HEPES to obtain required Na+ concentrations. 
Fluorescence intensities of HL60 cells exposed to HlyA or controls were 
measured using a fluorescence microscopy system for ratiometric determination of 
intracellular ion concentrations. Cells were immobilized on poly-L-lysine (Sigma 
Chemical Co., St. Louis) coated cover slips (12 mm-diameter) installed in open cell 
chambers: Cell suspension (500 µl) were pipetted onto each cover slip and allowed to 
settle by gravity for 1-5 minutes before replacing the suspension buffer with the 
appropriate experimental buffer. 
Microscopic fields including at least 6 cells were imaged in real time using an 
inverted microscope fitted with an intensified charge-coupled device camera (Photon 
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Technology International, New Jersey). Digitized images were collected before and after 
exposure to Hly A and controls by monitoring the 510 nm fluorescence emissions 
generated by 360/380 nm and 365/380 nm excitation of fura-2 or SBFI loaded cells, 
respectively. These images were stored and then analyzed using software (Image Master 
2.0, Photon Technology International, New Jersey) for measurement of fluorescence 
intensity in selected regions of interest in the microscopic field. 
The following equation was used to calculate [Ca2+]i (Grynkiewicz et a/,1985): 
where R is the ratio in emission intensities observed at the 2 excitation wavelengths. The 
maximal ratio (Rmax) was determined by exposure to the Ca2+ ionophore, 4-Br-A23187 
(10 µM), or to gramicidin (10 µM) in the presence of 1 mM Ca2+ (Ca-HBSS) or 150 mM 
Na+-HEPES, respectively. The minimal ratio <Rmin) was determined in a separate cell 
chamber by incubating HL60 cells in the absence of extracellular Ca2+ for 20 minutes 
prior to image acquisition. No autofluorescence was detected at any of the excitation 
wavelengths and, therefore, no background subtractions were required. The dissociation 
constants (Kd) used for Fura-2- or SBFI-loaded HL60 cells were 150.5 nM and 3.8 mM, 
respectively. Beta (~) is a ratio-generated constant calculated using the 380 nm 
excitation wavelength at zero [cation] and saturating fluorescent indicator conditions. 
Preliminary wavelength scans of loaded cells were conducted to confirm appropriate 
selection of excitation wavelengths. 
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Measurement of intracellular Ca2+ concentrations in cell suspensions 
For cell suspension (population) studies, Fluo-3 was used for measurement of 
[Ca2+]i. HL60 cells were loaded using the acetoxymethyl ester of Fluo-3 (Fluo-3/AM, 
Molecular Probes Inc., Eugene), as described for Fura-2. Briefly, Fluo-3 suspensions 
were incubated with Fluo-3 AM for 30 minutes at 22°C while constantly mixing on a cell 
rotator (Angenics, Cambridge). Sufficient Fluo-3 AM (in DMSO containing 0.14% 
pluronic acid) was added to the cell suspensions to achieve a final concentration of 5 µM. 
Loaded cells were then centrifuged at 200 x g and 4°C for 10 minutes, the supernatant 
was discarded, and the cells were resuspended in 10 ml PBS before centrifuging again at 
200 x g and 4°C for 10 minutes. After discarding the supernatant, cells were resuspended 
in 3 ml Ca-HBSS, enumerated by hemocytometer and then resuspended in Ca-HBSS to 1 
x 101 cells/ml. 
The effects of IIlyA and controls on [Ca2+]i in Fluo-3-loaded HL60 cells were 
tested in 96-well flat bottom microtiter plates (Corning Glass Works, Corning). Ten 
microliters of 25 mM CaCl2 (Sigma Chemical Co., St. Louis) and 2 µl antifluoroscein 
antibody (Molecular Probes, Eugene), diluted 1 :5 in PBS, were added in sequence to 250 
µl of cell suspension. The antifluoroscein antibody quenched fluorescence of 
extracellular indicator. Thereafter, 25 µl of diluted toxin or control preparations were 
added to wells, lids were placed on the plates, and the plates were incubated at 3 7°C. 
Fluorescence (490 nm excitation, 523 nm emission) was measured at times indicated for 
each specific experiment, using a spectrofluorometer (Victor2, Perkin Elmer). 
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Experiments were terminated by centrifugation at 200 x g at 4°C for 5 minutes. All 
experiments included quadruplicate wells for each of the primary treatments. 
Cytosolic calcium was determined using the following formula by Kao et al 
(1989): 
using a Kd value of 358 nM, as determined in previous studies (Cudd et al, 1999). 
Maximum fluorescence (Fmax) was determined by exposing control cells to 4-bromo 
A23 l 87, measuring fluorescence after quenching by addition of 20 µl 20 mM MnCh 
CF Mn), and then using the formula: 
Fmax = + Fb1cg 
where Fb1cg is the fluorescence emitted by Fluo-3 - loaded cells in the absence of an 
excitation beam. Minimum fluorescence CF min) was determined using the formula: 
Fmin = ____ +Fb1cg 
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Estimation of changes in voltage potential of isolated HL60 cells 
Changes in voltage membrane potential were studied using the fluorescent 
indicator, bis-1,3-dibutylbarbituric acid trimethine oxonol (DiBAC4, Molecular Probes, 
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Eugene). Changes in membrane potential cause a shift in the oxonol chromophore 
between a membrane binding site and the aqueous region on the surface of the 
membrane, as described by George et al (1988). HL60 cells harvested in lOmM HEPES 
buffered DMEM (pH 7 .1) were prepared as described above. Cells were loaded with 
fluorescent indicator by adding 200 µl of 250µM DiBAC4in DMSO to 10 ml suspension 
to yield 50 µM DiBAC4. The suspension then was mixed gently for 1 minute before 
incubating in the dark at 37°C with 5% CO2 for 29 minutes. Loading was terminated by 
washing 3 times in 1 OmM HEPES buffered DMEM ( centrifugation for IO minutes at 200 
x g). The final pellet was resuspended in 10 ml 1 mM Ca-HBSS. 
Change in voltage potential was assessed by measuring the intensity of 
fluorescence emission at 512 nm generated by excitation at 488 nm. Based on the linear 
correlation between emission intensity and voltage potential and the absence of any 
specific interest in quantifying voltage potential, non-calibrated raw intensity data were 
used to assess the effects of HlyA on this response variable. The positive control 
employed in these studies was 60 mM KCl, which causes membrane depolarization. 
Effects of HlyA on [Na +L,, [Ca2]i,, and plasma membrane potential and the role of 
VOCC. 
The involvement of VOCC in HlyA-induced increase in [Ca2+]i was studied by 
investigating whether HlyA was capable of causing transmembrane flux of the 
monovalent cation, Na\ and changes in membrane voltage, the principal triggers most 
likely to cause opening of VOCC, and whether any HlyA-induced effects on 
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transmembrane cation flux could be inhibited by using the VOCC inhibitors, verapamil 
and nifedipine. The ability of IIly A to induce an increase in [Ca2+]i was first confirmed 
by exposing HL60 cells loaded with Fura-2 to IDyA (0.25, 0.5, and 1 TU/ml), IIlyAc, and 
4Br-A23187 (40 µM), and measuring fluorescence emission of individual cells at 2 
second intervals, before and for 15 minutes after toxin addition. Effects of HlyA on 
[Na+]i were studied by exposing SBFI-loaded HL60 cells to HlyA (1 and 5 TU/ml), 
IDy Ac, or gramicidin, and measuring [Na +]i of individual cells before and at 5 second 
intervals thereafter for 20 minutes. In an attempt to correlate effects of HlyA on 
monovalent cation flux with changes in membrane voltage potential, HL60 cells loaded 
with DiBAC4 were then exposed to HlyA (1 and 5 TU/ml), HlyAc, and KCl, and the 
fluorescence emissions of individual cells were measured at 5-second intervals before 
and for a period of 20 minutes after toxin exposure. KCl served as a positive control to 
confirm the functionality of the fluorescent indicator. Finally, effects of VOCC inhibitors 
on HlyA-induced increase on [Ca2+]i were tested, both in individual cells as well as in cell 
suspensions, by exposing HL60 cells to Hly A in absence or presence of verapamil or 
nifedipine. HL60 cells were pretreated with drug solvent (ethanol) or 0.5, 5, or 50 µM 
verapamil for 20 minutes prior to IDy A exposure. 
In anticipation of the possibility that the hypothesized mechanism of HlyA 
intoxication involving influx of Ca2+ via VOCC would not be supported by the 
experiments described above, an additional study was designed to explore other 
mechanisms ofIDyA-induced increase in [Ca2+]i, such as influx of Ca2+ across the plasma 
membrane via ROCC and release of Ca2+ from intracellular stores: The possible 
involvement of these other mechanisms was explored in a preliminary experiment by 
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pretreating HL60 cells with 50 µM verapamil, 500 µM LaCh, or 500 µM MgCh before 
exposing Fluo-3 - loaded cells to 1 TU/ml IIlyA or HlyAc .. Lanthanum chloride and 
MgCh are inhibitors of plasma membrane Ca2+ channels (including both VOCC and 
ROCC) and release of Ca2+ via Ry-Ron vescicular Ca2+ stores, respectively. 
Results 
Growth patterns of the W AM 582 and W AM 783 bacterial strains were virtually 
identical, but only culture supernatant from W AM 582 caused any lysis of target sRBC. or 
HL60 cells, thus confirming that the Illy Ac. produced by W AM 783 served as a suitable 
negative control for the partially purified IIlyA produced by W AM 582. Comparison 
between lytic effects ofIIlyA on sRBC versus HL60 cells revealed that the former were 
much more sensitive: Percent specific lysis values of 50% were achieved at 1 :64 and 
1:4,200 dilutions of 1 TU/ml IIlyA incubated with HL60 and sRBC, respectively. The 
relative sensitivities of these cells confirmed the necessity of basing selection ofHlyA 
dilutions used in each experiment on activity against HL60 cells rather than using the 
more widely employed sRBC assay. 
Single HL60 cell fluorescence studies confirmed that IIlyA exposure causes an 
oscillatory increase in [Ca2+]i, which was more pronounced at the lower toxin 
concentrations (Figure 7). IIlyAc. failed to produce any change in [Ca2+]i. Exposure of 
HL60 cells to Illy A also caused significant oscillatory increases in [Na +]i that were 
similar in magnitude and frequency to those caused by the positive control, gramicidin 
(Figure 8). Again, the lower 1 TU/ml IIlyA concentration paradoxically produced a 
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greater response than that produced by the higher 5 TU/ml concentration, which was no 
different from that of the Illy.Ac. negative control. However, these effects of Illy A on the 
distribution of monovalent and divalent cations across the plasma membrane failed to 
affect membrane voltage potential, as measured by fluorescence intensity ofDiBAC4 
(Figure 9). Exposure of these HL60 cells to KCl, the positive control, confirmed that the 
assay methodology would have identified any changes in membrane potential in response 
to HlyA had they occurred. 
Studies involving imaging of individual cells revealed that the VOCC inhibitor, 
verapamil, significantly attenuated the increase in [Ca2+]i induced by Hly A, but only for a 
brief period after initial exposure to the toxin (Figure 10). Similarly, verapamil 
significantly inhibited Illy A-induced increase in [Na+]i, but only when used at the high 50 
µM concentration (Figure 11). Studies involving HL60 cell suspensions were less 
definitive regarding inhibitory effects ofverapamil: The 0.5 µMand 5 µM 
concentrations ofverapamil failed to cause significant inhibition of Illy A-induced 
increase in [Ca2+]1 (Figure 12). However, when the much larger 50 µM concentration of 
verapamil was employed, Illy A-induced increase in [Ca2+]i was enhanced, at both the 1 
TU and 4 TU toxin concentrations. Clearly, the lack of a concentration-dependent 
inhibitory effect ofverapamil on Illy A-induced increase in [Ca2+]i and the inhibitory 
effects ofverapamil on Illy A-induced increase in [Na+]i were not representative of a 
specific action on VOCC, thus bringing into question previous assumptions that 
inhibitory effects of verapamil on RTX toxin-induced increase in [Ca2+]i involved influx 
of extracellular Ca2+ through VOCC. Indeed, when the effects of verapamil were 
compared with those produced by lanthanum and MgCh, it was clear from the significant 
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inhibitory effects of the latter two agents that other mechanisms of [Ca2+]i must be 
investigated (Figure 13). 
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Figure 3. Growth rate (OD6oo) of Escherichia coli WAM 582 and WAM 783 strains and 
ability of culture supematants to cause lysis of sRBC (%Hb release). After a 
2-hour lag period, strains grew exponentially. Maximum HlyA production, 
estimated by sRBC lytic activity of culture supematants, was achieved by 7 
hours ofWAM 582 culture at 37°C, 5% CO2. 
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Figure 4. SDS-P AGE of E. coli W AM 582 and W AM 783 strains (n = 3), indicating 
multimeric banding pattern characteristic of partially purified preparations of 
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Figure 5. Effects of WAM 582 (HlyA), WAM 783 (HlyAc_), and WAM 971 toxin 
preparations on the release of LDH and Hb from exposed HL60 cells and 
sRBC, respectively. Isolated HL60 cells were exposed to dilutions of toxin 
preparations for 60 minutes (n = 3). HlyA caused lysis of both sRBC and 
HL60 cells, while preparations from the control strains, W AM 783 and W AM 
971, had no effect on cell integrity. HlyA activities of l TU were achieved by 
dilutions of approximately 1 :64 and 1 :4,096 for HL60 cells and sRBC, 
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Figure 6. Mean(± SD)% specific LDH release from HL60 cells exposed to 5 TU/ml 
HlyA (n = 3). Maximal effects were achieved by 60 minutes of incubation. 
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Figure 7. Mean(± SD) [Ca2+]i of individual HL60 cells (n = 6) before and after addition 
(arrow) of different concentrations (TU/ml) ofHlyA, 4Br-A23187, or Illy.Ac .. 
Lower concentrations of HlyA and 4Br-A23187 caused higher oscillatory 
increases in [Ca2+]i compared with 5 TU/ml HlyA. 
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Figure 8. Mean (:!. SD) [Na+]i of individual HL60 cells (n = 6) before and after addition 
(arrow) of different concentrations (TU/ml) ofHlyA, gramicidin-D, or HlyAc .. 
The lower I TU/ml concentration of HlyA and Gramicidin-D caused higher 
oscillatory increases in [Na+]i compared with the 5 TU/ml HlyA. 
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Figure 9. Mean(::!:. SD) fluorescence intensity emitted by DiBAC4 indicating changes in 
plasma membrane voltage potential of individual HL60 cells (n = 6) before 
and after addition (arrow) of different concentrations (TU/ml) of HlyA, KCl, 
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Figure 10. Mean (±. SD) effects of the VOCC inhibitor, verapamil, on HlyA-induced 
increase in [Ca2+]i. Individual cells (n = 6) were incubated for 20 minutes 
with different concentrations of verapamil (5 µM or 0.5 µM) or the drug 
solvent, ethanol (EtOH), before exposure to HlyA, HlyAc-, or 4Br-A23187. 
Both concentrations of verapamil significantly inhibited HlyA-induced 
increase in [Ca2+]i at 2 minutes after addition of toxin, however, there were no 
significant effects of verapamil at 4, 6, 8, and 10 minutes thereafter (as 
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Figure 11. Mean (±. SD) effects of the VOCC inhibitor, verapamil, on HlyA-induced 
increase in [Na +]i. Individual cells (n = 6) were incubated for 20 minutes with 
different concentrations of verapamil (0.5 µM, 5 µM, or 50 µM) or drug 
solvent (EtOH), before exposure to HlyA (1 TU/ml) or HlyAc .. The highest 
concentration of verapamil (50 µM) significantly inhibited HlyA-induced 
increase in [Na +]i at 2 minutes after addition of toxin, however, there were no 
significant effects of verapamil at 4, 6, 8, and 10 minutes thereafter (as 
determined by unpaired t tests, P < 0.05). 
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Figure 12 . . Mean (.:!:. SD) effects of the VOCC inhibitor, verapamil, on HlyA-induced 
increase in [Ca2+]i. Cell suspensions (n = 3) were incubated for 20 minutes 
with different concentrations of verapamil (0.5 µM, 5 µM, or 50 µM) or drug 
solvent (EtOH), before exposure to HlyA (1 TU/ml or 4 TU/ml) or HlyAc_. At 
lower concentrations, verapamil had no significant effects on HlyA-induced 
increase in [Ca2+]i. However, at 50 µM verapamil enhanced the increase in 
[Ca2+]i induced by both the 1 TU/ml and 4 TU/ml concentrations of HlyA, as 
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Figure 13. Mean (~ SD) effects of verapamil, nifedit>ine, lanthanum, and MgCh 
(Magnesium) on HlyA-induced increase in [Ca2+]i of suspended populations 
of HL60 cells (n = 3). In contrast to the VOCC inhibitors, verapamil and 
nifedipine, pretreatment with La3+ and Mg2+ significantly attenuated the 
HlyA-induced increase in [Ca2+]1, as determined by Scheffe's test (P < 0.05). 
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Discussion 
Previous studies reported that pharmacological inhibitors ofVOCC were capable 
of inhibiting the increased [Ca2+]i induced by RTX toxins (Cudd et al, 1999; Ortiz-
Carranza and Czuprynski, 1992; Hsuan et al, 1998), including HlyA (Uhlen et al, 2000). 
These observations served as the basis for the hypothesis underlying the present phase of 
study; that increase in [Ca2+]i induced by HlyA is caused by influx of extracellular Ca2+ 
through VOCC in the plasma membrane and that opening of these VOCC occurs in 
response to changes in membrane potential following HlyA-induced transmembrane flux 
of monovalent cations, including Na+. 
Initial studies were supportive of this hypothesis and confirmed that Hly A does 
cause marked increases in both [Ca2+]i and [Na +]i. In individual HL60 cells, these 
increases in monovalent cation concentration were characterized by oscillatory patterns 
with frequencies in the range of 1 - 4 minutes. These patterns of response were very 
similar to those observed in renal epithelial cells exposed to lower sublytic 
concentrations of Hly A (Uhl en et al, 2000; Laestadius et al, 2002). Low frequency Ca2+ 
oscillations in renal epithelial cells are believed to activate host defense mechanisms, 
particularly synthesis of cytokines, such as interleukin-6 and interleukin-8. In contrast to 
low concentrations of Hly A, exposure of renal epithelial cells to high concentrations 
caused sustained increases in [Ca2+]i and cell lysis. In the present study, exposure to high 
concentrations of HlyA in the range of 4 - 5 TU/ml generally caused relatively little 
increase in [Ca2+]i, possibly because these cells were intoxicated so rapidly that they were 
incapable of responding in a more controlled manner. Indeed, the resistance of HL60 
cells to HlyA-induced lysis, relative to sRBC, and the Ca2+ oscillations caused by 
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exposure to low concentrations of HlyA suggest that HL60 cells and other related 
leukocytes may be capable of mounting a coordinated defense against Hly A involving 
controlled flux of Ca2+ across the plasma and organelle membranes. 
Although HlyA was observed to increase both [Ca2+]i and [Na+]i, in accordance 
with the study hypothesis, subsequent experiments involving investigation of HlyA 
effects on membrane voltage potential and effects of verapamil failed to support a 
significant role for VOCC: HlyA did not cause any change in membrane voltage 
potential, the trigger generally responsible for opening of VOCC. Furthermore, 
verapamil, the VOCC inhibitor, was unable to inhibit HlyA-induced increase in [Ca2+]i in 
a selective and dose-dependent manner. While it is possible that VOCC may still be 
involved in the mechanism of intoxication employed by HlyA, it is probable that 
inhibitory effects of verapamil and other VOCC inhibitors are due to nonspecific effects 
on a variety of other membrane transport mechanisms, including those responsible for 
HlyA-induced increase in [Na+]i. 
Other Ca2+ transport mechanisms that may be involved include ROCC in the 
plasma membrane and release of Ca2+ from intracellular stores. Transport of Ca2+ across 
the plasma and organelle membranes is closely coordinated (Putney et al, 2001): Entry 
of Ca2+ across the plasma membrane usually triggers mobilization of intracellular Ca2+ 
stores through activation of Ry-R channels, in a process called Ca2+-induced Ca2+ release. 
Furthermore, release of Ca2+ from intracellular stores of non-excitable cells, such as 
leukocytes, may stimulate influx of Ca2+ through ROCC in the plasma membrane. In 
addition to Ry-R, release of Ca2+ from intracellular stores may also involve IP3 (Berridge, 
1993). Considering that eukaryotic cell types employ [Ca2+]i as an ubiquitous signaling 
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mechanism for a wide range of cell functions, it is reasonable to expect that multiple 
mechanisms of Ca2+ transport are involved in HlyA intoxication of HL60 cells. Indeed, 
the preliminary experiments testing the relative effects of verapamil, LaCh, and MgCh 
provide persuasive circumstantial evidence that influx of Ca2+ via ROCC and release of 
Ca2+ from the ER via Ry-R activation are important contributors to HlyA-induced 
increase in [Ca2+]i. Clearly, the present hypothesis describing an exclusive role for 
VOCC in HlyA-induced increase in [Ca2+]i must be abandoned in favor of a more 
comprehensive alternative hypothesis addressing contributory roles ofROCC and release 
of Ca2+ from intracellular stores. 
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CHAPTERV 
ROLES OF RECEPTOR-OPERATED CALCIUM CHANNELS AND 
INTRACELLULAR CALCIUM STORES IN INCREASED INTRACELLULAR 
CALCIUM CONCENTRATION INDUCED BY ESCHERICHIA COLI ALPHA 
HEMOLYSIN 
Introduction 
Investigation into the mechanisms involved in HlyA-induced [Ca2+]i increase 
requires consideration of the contributions of ROCC and the role of intracellular Ca2+ 
store release. A wide range of cell types possess the ability to generate intracellular Ca2+ 
signals upon binding of ligands (such as neurotransmitters, hormones, and growth 
factors) to receptors on the cell surface (Braun et al, 2001 ). Release of Ca2+ from 
intracellular stores, particularly the ER, also involves receptors, including IP3-R and Ry-
R. Inositol triphosphate receptors are sensitive to IP3, which is a catalytic product of 
PLC, a membrane-associated enzyme (Ackerman et al, 1999). Ryanodine receptors are 
also responsible for Ca2+ release from ER stores and are modulated by ryanodine itself, 
caffeine, Ca2+, Mg2\ and calmodulin (Berridge, 1993). Depletion of ER Ca2+ stimulates 
replenishment of intracellular stores, which is accomplished through Ca2+ channels in the 
plasma membrane, a process termed capacitative calcium entry (Putney, 1986). The 
resultant increase in [Ca2+]i governs a wide range of important cellular processes, 
including cell growth and differentiation as well as apoptosis and cell death, and it is 
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probable that these mechanisms are involved in cellular responses to HlyA, both those 
that mediate activation of host defenses as well as those that ultimately result in cell lysis. 
Interaction of Hly A with the target cell surface has been demonstrated to involve 
the LF A-1 heterodimer surface protein, collectively termed 132-integrin (Lally et al, 
1997). Based on research performed by Lally and coworkers, as well as the results of the 
first phase of the present research (see Chapter N), it is postulated that binding of HlyA 
to LFA-1 promotes intimate contact with the cell and activation of a signal transduction 
process that culminates in the release of Ca2+ from intracellular stores. Considering the 
possible involvement of IP3-R - mediated release of Ca2+ from the ER, it is likely that 
transduction of this signal relies on activation of PLC, the y-isoform (PLCy2) of which is 
expressed by HL60 cells (Bianchini et al, 1993). Binding to 132-integrin is believed to be 
linked to activation of tyrosine kinase, which in tum phosphorylates PLCy2, thus 
promoting generation of IP3. However, control of other types of Ca2+ influx channels 
may also be linked to activation of PLC-linked receptors (Zhu et al 1998). 
Therefore, the objectives of this phase of study were: (1) to investigate the 
mechanisms of HlyA-induced increase in [Ca2+L by employing specific pharmacological 
inhibitors of several alternative cellular pathways involved in release of intracellular 
stored Ca2+ and receptor-mediated transport of Ca2+ across the plasma membrane; and (2) 
to compare the effects of HlyA on HL60 cells and a similar cell line (K562) that does not 
express LFA-1 surface receptors. 
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Materials and Methods 
Preparation of E. coli HlyA 
Culture supematants were harvested from E. coli strains W AM 582, W AM 783, 
and W AM 971, and Hly A and toxin controls were prepared as described previously in 
Chapter IV. Similarly, methods for toxin storage and assay of activity were identical to 
those used previously. 
Preparation of HL60 and K562 cells 
In vitro cell lines were obtained from American Type Cell Culture (ATCC). 
Methods for culture, harvesting, and preparation of HL60 and K562 cells were identical 
to those employed previously for performance of HL60 cell suspension (population) 
studies. Cells were loaded with Fluo-3 for determination of [Ca2+]i, the assays were 
calibrated, and [Ca2+]i values were calculated using the methods and formulae described 
previously in Chapter IV. 
Pretreatment of HL60 cells with pharmacoloiical inhibitors 
Assays were conducted in 96-well plates. Wells containing 4 x 104 HL60 or 
K562 cells and anti-fluoroscein Ab (Calbiochem, La Jolla, CA) in 100 µl of assay buffer 
were exposed to 5, 1, 0.5, or 0.1 TU/ml of HlyA or corresponding concentrations of 
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HlyAc .. Changes in [Ca2+]i were monitored before and after exposure (-2, -1 ,0, 2, 5 and 
every 5 minutes thereafter for a minimum of 60 minutes) to toxin preparations at room 
temperature. 
Initial experiments compared the effects of Hly A on HL60 cells and K562 cells. 
Thereafter, pharmacological inhibitors were used in a systematic fashion to explore the 
involvement of relevant ROCC and intracellular Ca2+ release mechanisms. Prior to 
addition of HlyA or HlyAc., cells were incubated with the pharmacological inhibitors 
(genistein, wortmannin, xestospongin, MgCh, thapsigargin, LaCh, or SK&F-96365) or 
solvent controls for 20 minutes (or as otherwise indicated below) in the dark. 
Genistein (Calbiochem, La Jolla, CA) is a naturally occurring isoflavanoid 
phytoestrogen that acts as a strong inhibitor of protein tyrosine kinases (PTK) responsible 
for activation of PLCy (Husain and Jafri, 2002). An 8 mg/ml stock solution prepared in 
EtOH:DMSO (4:1) and stored at -20°C was diluted to 300 µg/ml in EtOH and added to 
HL60 cell suspensions to achieve final concentrations of 30, 10, 1, and O µM. 
Wortmannin (Wm, Sigma Chemical, St. Louis, MO), derived from Penicillium 
.fumiculosum, is an inhibitor of phosphatidylinositol kinases, which are responsible for 
synthesizing the substrate of PLC-catalyzed production of lP3 (Broad et al, 2001 ). 
Wortmannin was prepared as a 300 µM stock solution in EtOH:DMSO (4.6:0.4) and 
added to HL60 cell suspensions to achieve final concentrations of 30, 10, 1, and O µM. 
Release of Ca2+ from ER by activation of lP3-R was inhibited using xestospongin C 
(XeC, Gafni et al, 1997), which was prepared as a 200 µM stock solution in EtOH. Final 
concentrations of XeC in HL60 cell suspensions were 20, 2, 0.2 or O µM. The divalent 
cation, Mg2+, was used to inhibit release of Ca2+ from ER via Ry-R. HL60 cell 
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suspensions were exposed to 5 mM Mg2+ by addition of appropriate volumes of a 50 mM 
stock solution of MgCh in 1 mM Ca-HBSS immediately prior to HlyA or HlyAc-
exposure. Thapsigargin (Tg), a sesquiterpene lactone that inhibits active uptake of Ca2+ 
into the ER by sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) (Thastrup et 
al, 1990), was used to deplete ER Ca2+ stores prior to exposure to Bly A. Thapsigargin 
was prepared by addition of a 5 mM stock solution in EtOH to cell suspensions to 
achieve final concentrations of 0.5, 0.1, 0.05, and O mM. The period of pretreatment was 
30 minutes. The non-selective ROCC inhibitor, lanthanum (La3+) (Sigma Chemical, St. 
Louis, MO) competes with Ca2+ for binding to extracellular sites, including Ca2+ 
channels. Due to the large valence shell of La3+, it precludes entry of Ca2+ through these 
channels. LaCh was used at 1, 0.5, 0.05 or O mM and was incubated with HL60 cell 
suspensions for 15 minutes prior to addition of toxin in the presence of 0.5 mM Ca-
HBSS. The final assay volume was 250 µI. Finally, SKF-96365 was used as a specific 
inhibitor ofROCC involved in capacitative calcium entry (Krautwurst et al. 1993; Leung 
et al, 1993). A 200 µM stock solution of SKF-96365 in ddH20 was added to HL60 cell 
suspensions to yield final concentrations of 20, 15, 5 or O µM. Cells were pretreated for 
10 minutes prior to addition of toxin in the presence of 1 mM Ca-HBSS. 
Results 
Exposure of K562 cells, which do not express ~2-integrin (Lally et al, 1997), to a 
wide range of HlyA concentrations did not induce cell lysis, as determined by release of 
the endogenous enzyme, LOH (Figure 14). However, exposure of sRBC and HL60 cells 
60 
to the same HlyA concentrations caused rapid and serious damage to these cells, as 
determined by Hg and LDH release, respectively. Exposure of K562 cells to HlyA did 
cause a small increase in [Ca2+]i compared with HlyAc. - stimulated cells (Figure 15). 
This increase in [Ca2+]i was observed during K562 cell exposure to 5 TU/ml HlyA and 
was absent in the presence of either 1 or 0.5 TU/ml HlyA. However, despite the ability 
of a high dose of HlyA to cause increased [Ca2li, this effect was not correlated with cell 
lysis (Figure 15) and was much less marked than that observed in HL60 cells (Figure 16). 
Pretreatment of HL60 cells with genistein, the PLCy inhibitor, significantly 
attenuated the increase in [Ca2+]i caused by all concentrations of Hly A tested (Figure 17). 
Similarly, PLCy substrate depletion using the phosphatidylinositol kinase inhibitor, 
wortmannin, depressed HlyA-induced increase in [Ca2+]i, but the Ca2+ response was not 
completely ablated and significant increases in [Ca2+]i still occurred in the presence of 
HlyA (Figure 18). Xestospongin C, the inhibitor of lP3-R- mediated Ca2+ release from 
the ER, significantly inhibited HlyA-induced [Ca2+]i increase, although [Ca2+]i still was 
significantly higher than the corresponding HlyAc. treatment at the 5 TU/ml dose ofHlyA 
(Figure 19). Incomplete inhibition by XeC and wortmannin, both of which suppress lP3-
mediated Ca2+ release from ER, suggested that there may be redundancy in mechanisms 
employed by HlyA to increase [Ca2+]i. This suspicion was confirmed by experiments 
investigating the involvement of the parallel Ry-R- mediated Ca2+ release mechanism: 
A high concentration of Mg2+ (5 mM in the presence of 1 mM Ca2+) caused a 33% 
reduction in the Ca2+ response induced by 5 TU/ml HlyA and a 50% reduction when 
HL60 cells were exposed to I TU/ml Hly A (Figure 20). The contribution of intracellular 
stored Ca2+ to Hly A-induced increase in [Ca2+]i was further confirmed by the effect of 
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Tg, the SERCA inhibitor (Figure 21). In the absence of HlyA, Tg induced capacitative 
Ca2+ entry. In the presence of HlyA, the effect of Tg depended on the relative balance 
established between capacitative Ca2+ entry, which promoted increased [Ca2+]i, and 
depletion of ER Ca2+ stores, which limited the availability of stored Ca2+ that could 
contribute to an increase in [Ca2+]i via IP3-R and Ry-R mechanisms. The balance 
between these effects shifted towards the latter as the concentration of Tg was increased. 
Involvement of ROCC in HlyA-induced [Ca2+]i increase was investigated using 
LaCh and SKF-96365. Exposure of HL60 cells to 5, 1, and 0.5 TU/ml HlyA in the 
presence of 1 mM La3+, the nonspecific inhibitor of Ca2+ channels in the plasma 
membrane, caused a reduction in the Ca2+ influx and a decrease in [Ca2+]i over a 60 
minute time period (Figure 22). Treatment with less than 1 mM La3+ had no effect, 
indicating the requirement for a minimum threshold concentration. In contrast to LaCh, 
5 µM SKF-96365 had no effect on HlyA-induced [Ca2+]i increase, even at the higher 
concentrations of 15 µMand 20 µM (Figure 23). 
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Figure 14. Mean (± SD) % specific LDH and Hb release resulting from exposure of 
sRBC, HL60 and K562 cells to HlyA or Hly~. (n = 3). K562 cells, which do 
not express LFA-1 receptors, were resistant to the membrane damaging 
effects of HlyA. 
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Figure 15. Mean(± SD) effect ofHlyA on [Ca2+]; of K562 cell suspensions (n = 3). The 
response induced by HlyA at the 5 TU/ml was significantly higher than that 
induced by HlyAc- but significant lower than that induced by 4Br-A23 l 87, 
using a repeated measures analysis of variance (P < 0.05). Arrow indicates 











10 15 20 25 30 35 40 45 50 55 60 65 70 
Exposure Time (minutes) 
Key: • 40 µM 4-Br-A23187 • ST.U. HlyA 
EB I T.U. HlyA --0-- 0.5 T.U. HlyA 
e HlyAC- Mutant 
Figure 16. Mean (± SD) effects of HlyA on [Ca2+]i of HL60 cell suspensions (n = 3). 
Responses induced by HlyA at the 0.5, 1, and 5 TU/ml were all significantly 
higher than that induced by HlyAc-, using a repeated measures analysis of 
variance (P < 0.05). When compared with the responses of K562 cells plotted 
in Figure 15, HL60 cells demonstrated a large concentration-dependent 
response when exposed to HlyA, relative to the effect of 4Br-A23187. Arrow 
indicates addition of HlyA or HlyAc_. 
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Figure 17. Mean (:!:. SD) effects of genistein (10 µg/ml) on HlyA-induced [Ca2+]i 
increase. HL60 cell suspensions (n = 3+ were exposed to 0.5, 1, and 5 TU/ml 
HlyA. Mean [Ca2+]i values in genistein-treated cells were significantly lower 
than corresponding untreated cells (EtOH), using repeated measures analysis 
of variance (P < 0.05). Arrow indicates addition ofHlyA or HlyAc_. 
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Figure 18. Mean(± SD) effects ofwortmannin (1 µM) on HlyA-induced [Ca2+]i increase. 
HL60 cell suspensions (n = 3) were exposed to I and 5 TU/ml HlyA. 
*Significant (P < 0.05) effects of wortmannin versus corresponding untreated 
control values (EtOH) were identified at discrete time points, using unpaired t 
tests. Arrow indicates addition ofHlyA or Hly.Ac_. 
67 
300 • 5 TU/ml-EtOH -0-- 5 TU/ml-20µM 
A l TU/ml-EtOH --tr-- I TU/ml-20µM 








0 10 20 30 40 50 60 
t Incubation time (minutes) 
Figure 19. Mean (~ SD) effects of XeC (20 µM) on HlyA-induced [Ca2+]i increase. 
HL60 cell suspensions (n = 3) were exposed to 1 and 5 TU/ml HlyA. Mean 
[Ca2+]i values of cells treated with XeC and exposed to 5 TU/ml HlyA were 
significantly lower than corresponding untreated cells (EtOH), using repeated 
measures analysis of variance (P < 0.05). Arrow indicates addition of HlyA 
or HlyAc .. 
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Figure 20. Mean (± SD) effects of Mg2+ (5 mM) on HlyA-induced [Ca2+]i increase. 
HL60 cell suspensions (n = 3) were exf+osed to 1 and 5 TU/ml HlyA. Mean 
[Ca2+]i values of cells treated with Mg+ and exposed to 5 TU/ml HlyA were 
significantly lower than corresponding untreated cells (HBSS), using repeated 
measures analysis of variance (P < 0.05). Arrow indicates addition of HlyA 
or HlyAc_. 
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Figure 21. Mean (.:t SD) effects of Tg (0.05, 0.1, and 0.5 mM) on HlyA-induced [Ca2+]; 
increase. HL60 cell suspensions (n = 3) were exposed to l HlyA. Mean 
[Ca2+]i values of cells treated with 0.5 mM Tg were significantly lower than 
corresponding untreated cells (EtOH), using repeated measures analysis of 
variance (P < 0.05). *Mean values for cells treated with lower concentrations 
of Tg (0.05 and 0.1 mM) were determined to be significantly higher than 
corresponding untreated (EtOH) values, using unpaired t tests (P < 0.05). 
Arrow indicates addition ofHlyA. 
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Figure 22. Mean(± SD) effects of La3+ (1 mM) on HlyA-induced [Ca2+]i increase. HL60 
cell suspensions (n = 3) were exposed to 0.5, l, and 5 TU/ml HlyA. Mean 
[Ca2+]i values of cells treated with La3+ and exposed to 1 and 5 TU/ml HlyA 
were significantly lower than corresponding untreated cells (HBSS), using 
repeated measures analysis of variance (P < 0.05). Arrow indicates addition 
ofHlyA or HlyAc_. 
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Figure 23. Mean(± SD) effects of SKF 96365 (5 µM) on HlyA-induced [Ca2+]i increase. 
HL60 cell suspensions (n = 3) were exposed to 0.5, 1, and 5 TU/ml HlyA. No 
significant effects of SKF 96365 were identified using repeated measures 
analysis of variance (P < 0.05). Arrow indicates addition ofHlyA or HlyAc_. 
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Discussion 
Experiments conducted in the initial phase of study (see Chapter IV) concluded 
that influx of Ca2+ through VOCC was unlikely to be the primary means whereby HlyA 
caused increased [Ca2+]i in HL60 cells. Instead, preliminary studies suggested that 
ROCC and release of Ca2+ from intracellular stores were more important contributors to 
this response. Therefore, the overall goal of this phase of research was to explore the 
specific involvement of mechanisms of intracellular Ca2+ control mediated by lP3-R and 
Ry-R, and the interaction between these pathways and binding of HlyA to LFA-1 
receptors expressed on the surface of HL60 cells. Experiments designed to address this 
goal employed pharmacological inhibitors of critical steps in these pathways and 
comparison between HL60 cells and K562 cells, which do not express LF A-1 but are 
otherwise very similar to HL60 cells. 
Previous studies conducted by Lally et al (1997) indicated that interaction of 
Hly A with the plasma membrane of target cells was mediated by specific binding to 
aCD1 la and aCD18, which constitute the LFA-1 receptor. The cell surface ~2-integrin 
protein, LFA-1, is an important cell adhesion receptor molecule involved in cell signaling 
(Sirim et al, 2001). By interacting with its APC ligand, ICAM-1, the LFA-1 receptor 
potentiates Ca2+ signaling by T-cell receptors (Abraham et al, 1999) and promotes T-cell 
activation. The LFA-1 receptor also mediates activation of macrophage and neutrophilic 
cell types, leading to degranulation, chemotaxis, and increased phagocytosis of 
potentially infectious particles. The inability of Hly A to cause significant lysis of K562 
cells, which are deficient in expression of LFA-1, provided strong circumstantial 
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evidence that this ~2-integrin protein serves as the cell surface receptor responsible for 
mediating many cellular consequences of exposure to illy A. Although this inability to 
cause lysis of K562 cells was correlated with lower increases in [Ca2+]i, compared with 
those observed in HL60 cells, the existence of even a limited increase in [Ca2+]i suggests 
that illy A also employs other parallel pathways for increasing [Ca2+]i that do not involve 
binding to LFA-1. 
Signal transduction pathways involving cell surface receptors and Ca2+ as a 
second messenger often are mediated by the enzyme PLC, which catalyzes the synthesis 
of IP3. The involvement of PLCy in HlyA-induced [Ca2li was confirmed by the 
inhibitory action of genistein, possibly by disruption of interactions occurring between 
the SH2 domain on PLCy and the LF A-1 surface protein. However, the specific manner 
in which PLCy may interact with LFA-1 has yet to be determined because while 
wortmannin, the phosphoinositol kinase inhibitor, was able to exert inhibitory effects at 
discrete times after exposure of HL60 cells to HlyA, these effects were not consistent 
over the ranges of incubation time and illy A concentration tested. 
The primary pathways for release of Ca2+ from intracellular storage sites, 
particularly the ER, are mediated by lP3-R and Ry-R. Significant effects of inhibitors on 
both of these pathways indicated that exposure of HL60 cells to Hly A causes recruitment 
of parallel and possibly redundant mechanisms to increase [Ca2+]i. Involvement of lP3 in 
the HlyA-induced [Ca2+]i response was directly investigated through the use of the lP3-R 
inhibitor, XeC, which significantly inhibited the effect of the high 5 TU/ml concentration 
ofHlyA, although little effect was observed at lower toxin concentrations. The effect of 
Hly A on [Ca2+]i was also sensitive to the presence of Mg2+. HL60 cells possess the Ry-
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R3 subtype, which occurs in non-muscle cell types (da Silva and Guse, 2000) and is 
negatively modulated by high concentrations of Mg2+. It is not yet clear what the relative 
contributions of IP3-R and Ry-R may be to Hly A-induced increase in [Ca2+]i. 
Furthermore, considering that Ca2+ itself may modulate the activities of lP3-R and Ry-R, 
additional studies are needed to explore whether these mechanisms are activated in 
response to changes in [Ca2+]i resulting from influx of extracellular Ca2+ across ROCC or 
whether binding to receptors on the cell surface stimulates release of stored Ca2+ via non-
Ca2+ second messengers, such as IP3 and cADPR. 
Nevertheless, it is clear from the experiments employing Tg that release of Ca2+ 
from intracellular stores is critical to HlyA-induced [Ca2+]i increase. By inducing 
intracellular Ca2+ release from and uptake into lP3-sensitive intracellular stores (Lytton et 
al, 1991; Thastrup et al, 1990; Bain et al, 1991), Tg limited the Ca2+ available for 
intracellular release and, at high concentrations, completely inhibited any increase in 
[Ca2+]i after exposure to HlyA. However, the effect of Tg appears to be complex and 
probably involves the competing influences of capacitative Ca2+ entry and limited 
availability of stored Ca2+, thus explaining the increased [Ca2+]i observed after 
pretreatment with 0.05 mM and 0.1 mM, and inhibition of [Ca2+]i increase after 
pretreatment with 0.5 mM Tg. Irrespective of the role of capacitative calcium entry in 
fine-tuning HlyA-induced increase in [Ca2+]i, it is doubtful that it plays a major role in the 
molecular pathogenesis of HlyA because SKF-96365, the specific inhibitor of ROCC 
involved in capacitative calcium entry, had no significant effect on changes in [Ca2+]i 
induced by HlyA. 
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While the present experiments demonstrate that release of Ca2+ from intracellular 
stores is a critical contributor to Hly A-induced [Ca2+]i increase, influx of extracellular 
Ca2+ across channels in the plasma membrane also plays an important role. The 
involvement of these channels was demonstrated by the inhibitory effects of La3+. 
Trivalent lanthanides have a large hydrated ionic radius and a cationic charge that 
promotes high affinity binding to anionic sites on the cell surface, especially those 
normally occupied by Ca2+ (Weiss, 1974). This action results in nonspecific inhibition of 
Ca2+ channels in the plasma membrane, including ROCC. Considering the lack of 
inhibitory effects of SKF-96365, the present experiments provided little clarification 
concerning the specific identity of ROCC that may be involved in the transmembrane 





Extraintestinal E. coli is a major cause of nosocomial infections involving 
bacteremia, peritonitis, and nephritis (Kreger et al, 1980), and HlyA production is 
recognized to be an important virulence factor in the pathogenesis of these diseases 
(Cavalieri et al, 1984). Exposure of many different cell types to HlyA, particularly 
leukocytes, leads to increased [Ca2+]i and subsequent degranulation, oxidative burst, 
eicosanoid production, and ultimately lysis (Czuprynski et al, 1991; Ortiz-Carranza and 
Czuprynski, 1992). Elucidation of the mechanisms whereby Hly A causes increased 
[Ca2+]i is critical to development of effective treatment of these diseases and was the 
focus of this research. 
Numerous researchers have reported (reviewed in Chapter 11) that HlyA is 
capable of directly disrupting the integrity of protein-free liposomes and planar lipid 
bilayers, suggesting that these effects lead to generation of transmembrane lesions or 
pore-like structures through which extracellular Ca2+ can be transported. Other studies 
employing inhibitors of VOCC (Cudd et al, 1999; Ortiz-Carranza and Czuprynski, 1992; 
Hsuan et al, 1998) suggested an alternative mechanism for increased [Ca2+]i involving 
influx of monovalent cations through membrane pores, changes in membrane voltage 
potential, and consequent opening of VOCC. While initial experiments confirmed that 
HlyA causes increases in [Na+]i and [Ca2+]i, these two events could not be correlated with 
any changes in membrane voltage potential, the principal trigger for activation of VOCC. 
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Furthermore, verapamil inhibited Hly-induced increases in both [Na +]i and [Ca2+]i, 
indicating that VOCC inhibitors lack specificity of action and cannot serve as a credible 
basis for assuming the primary involvement ofVOCC in the pathogenesis ofHlyA. 
Therefore, further studies were conducted that explored the role of other 
mechanisms of increased [Ca2+]i, including influx of Ca2+ through ROCC and release of 
Ca2+ from intracellular storage sites. Based on evidence that expression of the LFA-1 
receptor is necessary for full-blown intoxication by HlyA and the significant effects of 
pharmacological inhibitors on intracellular Ca2+ pathways involving PLC, IP3-R, and Ry-
R, it is clear that both influx of extracellular Ca2+ across plasma membrane channels and 
release of stored Ca2+ are important contributors to Hly A-induced increase in [Ca2+]i. 
The relative roles of intracellular release mechanisms mediated by IP3-R and Ry-R have 
yet to be determined, as is the relationship between release of Ca2+ from the ER and 
influx of extracellular Ca2+ through plasma membrane channels. While it is possible that 
these mechanisms of [Ca2+]i increase represent redundant pathways, it is more likely that 
the contribution of each varies according to the concentration ofHlyA and the duration of 
exposure, and whether the target cells are subject to sublytic versus lytic attack. 
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